Study of Methylnaltrexone in Opioid-Induced Constipation Patients

Summary

This is a multicenter, randomized, double-blind , placebo-controlled trail to investigate the safety and efficacy of subcutaneous methylnaltrexone for treating opioid-induced constipation in patients with advanced illness.

Timeline

Start

2015-04

Primary completion

2016-12

Completion

2017-04

Drugs

Indications